Brenda Finucane is associate director of the Autism and Developmental Medicine Institute at Geisinger in Lewisburg, Pennsylvania.
Brenda Finucane
Associate director
Autism and Developmental Medicine Institute at Geisinger
From this contributor
Q&A with Brenda Finucane: Building pipelines for genetic tests for autism
Most autistic people do not receive the medically recommended genetic tests for autism. Brenda Finucane and her colleagues want to change that.
Q&A with Brenda Finucane: Building pipelines for genetic tests for autism
By
Angie Voyles Askham
17 August 2021 | 6 min read
Explore more from The Transmitter
New Stanford initiative aims to build digital twin of human brain
The effort, funded by private donors, seeks to train the model on a trove of MRI and magnetoencephalography data that scientists plan to collect over the next five years—but questions about its scientific utility and feasibility remain.
New Stanford initiative aims to build digital twin of human brain
The effort, funded by private donors, seeks to train the model on a trove of MRI and magnetoencephalography data that scientists plan to collect over the next five years—but questions about its scientific utility and feasibility remain.
By
Natalia Mesa
2 November 2026 | 0 min watch
The genome offers a recipe, not a blueprint, for the brain
During brain development, genes set the rules and turn the knobs; self-organization does much of the rest.
The genome offers a recipe, not a blueprint, for the brain
During brain development, genes set the rules and turn the knobs; self-organization does much of the rest.
By
Ila Fiete
2 November 2026 | 8 min read
Autism research involving monkeys contends with uphill battle
Macaques and marmosets recapitulate the condition’s core traits better than mice can, but funding uncertainty and challenges at primate centers in the United States could make this work difficult to continue.
Autism research involving monkeys contends with uphill battle
Macaques and marmosets recapitulate the condition’s core traits better than mice can, but funding uncertainty and challenges at primate centers in the United States could make this work difficult to continue.
By
Diana Kwon
2 November 2026 | 8 min read